Skip to content

Clinical trials

Phase 2 Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Phase: Phase 2 Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20083
20101
20111
20124
20132
20144
20152
20173
20185
20191
20202
20213
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated6
Active, not recruiting3
Recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)3
Catalysis SL2
TesoRx Pharma, LLC2
AbbVie1
Akcea Therapeutics1
Albert Einstein College of Medicine1
Anelixis Therapeutics, LLC1
Aphaia Pharma US LLC1
Ascendis Pharma A/S1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases44
Diabetes Mellitus17
Glucose Metabolism Disorders14
Metabolic Diseases13
Autoimmune Diseases7
Diabetes Mellitus, Type 27
Diabetes Mellitus, Type 16
Gonadal Disorders6
Endocrine Gland Neoplasms5
Immune System Diseases5

Trials

Showing 76 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.